Enzymes for a Circular Future: Twogee Biotech Secures €2.16M

Avatar photo

As industries search for scalable ways to reduce emissions and move toward circular production models, Munich based Twogee Biotech has secured fresh capital to accelerate its mission of turning biomass residues into sustainable raw materials. The biotechnology startup has completed a €2.16 million seed financing round to advance its enzyme based platform for industrial biomass conversion.

The round includes investments from High Tech Gründerfonds and Bayern Kapital, alongside strategic partners AgriFoodTech Venture Alliance and Heinz Entsorgung. The backing reflects growing interest in technologies that enable the use of low value residual streams as feedstocks for bio based manufacturing.

Building Enzyme Solutions for Circular Industry

Founded in 2024 by Frank Wallrapp and Helge Jochens, Twogee Biotech focuses on developing customised enzyme solutions that help industrial partners convert biomass by products into second generation raw materials. The company’s primary focus is on producing sugars that can be used in bio and synthetic biology applications, replacing fossil based inputs.

Many industries generate large volumes of organic residues that remain underutilised due to technical complexity or economic constraints. Twogee aims to change this by providing tailored enzyme systems that enable efficient and predictable conversion of these materials into valuable inputs.

A Predictive Platform for Faster Development

At the core of Twogee Biotech’s approach is a predictive development platform that integrates enzyme screening, strain engineering, and fermentation. By combining these elements, the company helps partners shorten development timelines and reduce the risk typically associated with scaling up biotechnological processes.

This integrated workflow allows industrial customers to move more quickly from concept to pilot and eventually to full scale deployment. It also supports better utilisation of biomass feedstocks, contributing to lower CO₂ emissions and more efficient resource use.

According to CEO Frank Wallrapp, many industrial residual streams contain untapped economic potential. He said Twogee works closely with partners to unlock that value through solutions designed for seamless integration into existing processes, with clear commercial benefits.

Early Commercial Validation

Twogee Biotech has already completed initial minimum viable products and paid pilot projects with industrial partners, demonstrating early demand for its technology. These projects have helped validate the company’s development model and provided insights into how enzyme solutions can be adapted to different biomass streams and industrial contexts.

The startup’s ability to secure paying customers at an early stage has strengthened its commercial foundation and informed its product roadmap as it prepares for broader market adoption.

A Licensing Model for Decentralised Production

Rather than operating large centralised production facilities, Twogee Biotech plans to pursue a licensing model that enables customers to produce enzymes locally at their own sites. This approach is designed to reduce logistics costs, lower emissions, and support decentralised value chains.

By allowing enzyme production closer to where biomass residues are generated, the model aligns with broader industry efforts to build resilient and circular supply chains. It also gives industrial partners greater control over their production processes and cost structures.

Scaling Technology and Commercialisation

The newly raised capital will be used to further develop Twogee’s technology platform and advance commercialisation efforts. This includes expanding the company’s technical capabilities, strengthening partnerships, and supporting additional pilot and deployment projects.

As industries across food, agriculture, waste management, and materials look for practical solutions to decarbonise operations, Twogee Biotech is positioning itself as an enabling partner. By combining biotechnology, predictive development, and a flexible commercial model, the company aims to help transform residual biomass into a cornerstone of sustainable industrial production.

Total
0
Shares
Previous Post

Voyager Ventures Closes $275M Fund to Power the Next Industrial Era

Next Post

HERO Targets Dutch Trades With Software That Automates the Back Office

Related Posts